Cargando…

Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study

The underlying mechanisms of neuropathic pain remain to be elucidated. Basic animal research has suggested that lysophosphatidic acids, which are bioactive lipids produced by autotaxin from lysophosphatidylcholine, may play key roles in the initiation and maintenance of neuropathic pain. Here, we in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuwajima, Ken, Sumitani, Masahiko, Kurano, Makoto, Kano, Kuniyuki, Nishikawa, Masako, Uranbileg, Baasanjav, Tsuchida, Rikuhei, Ogata, Toru, Aoki, Junken, Yatomi, Yutaka, Yamada, Yoshitsugu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224112/ https://www.ncbi.nlm.nih.gov/pubmed/30408112 http://dx.doi.org/10.1371/journal.pone.0207310

Ejemplares similares

Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis
por: Hayakawa, Kentaro, et al.
Publicado: (2019)

Inhibition of autotaxin activity ameliorates neuropathic pain derived from lumbar spinal canal stenosis
por: Uranbileg, Baasanjav, et al.
Publicado: (2021)

Different Profiles of the Triad of Lysophosphatidylcholine, Lysophosphatidic Acid, and Autotaxin in Patients with Neuropathic Pain Diseases: a Preliminary Observational Study
por: Edamura, Tatsuma, et al.
Publicado: (2022)

Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model
por: Uranbileg, Baasanjav, et al.
Publicado: (2019)

Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
por: Kurano, Makoto, et al.
Publicado: (2022)

Suppressing postcollection lysophosphatidic acid metabolism improves the precision of plasma LPA quantification
por: Kano, Kuniyuki, et al.
Publicado: (2021)

Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma
por: Igarashi, Nozomi, et al.
Publicado: (2018)

Sphingosine 1‐phosphate lyase facilitates cancer progression through converting sphingolipids to glycerophospholipids
por: Uranbileg, Baasanjav, et al.
Publicado: (2022)

Genetic Polymorphisms of ENPP2 Are Possibly Associated with Pain Severity and Opioid Dose Requirements in Patients with Inflammatory Pain Conditions: Clinical Observation Study
por: Tsuchida, Rikuhei, et al.
Publicado: (2023)

Lysophospholipids in laboratory medicine
por: YATOMI, Yutaka, et al.
Publicado: (2018)

Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression
por: Takahashi, Chiharu, et al.
Publicado: (2017)

Increased mRNA Levels of Sphingosine Kinases and S1P Lyase and Reduced Levels of S1P Were Observed in Hepatocellular Carcinoma in Association with Poorer Differentiation and Earlier Recurrence
por: Uranbileg, Baasanjav, et al.
Publicado: (2016)

Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human
por: Sato, Masaya, et al.
Publicado: (2016)

Analysis of glycero-lysophospholipids in gastric cancerous ascites
por: Emoto, Shigenobu, et al.
Publicado: (2017)

Suppression of sphingosine 1-phosphate lyase retards the liver regeneration in mice after partial hepatectomy
por: Kageyama, Yuko, et al.
Publicado: (2020)

Autotaxin–lysophosphatidic acid–LPA (3) signaling at the embryo‐epithelial boundary controls decidualization pathways
por: Aikawa, Shizu, et al.
Publicado: (2017)

Analysis of urinary sphingolipids using liquid chromatography‐tandem mass spectrometry in diabetic nephropathy
por: Morita, Yoshifumi, et al.
Publicado: (2019)

Possible involvement of PS-PLA1 and lysophosphatidylserine receptor (LPS1) in hepatocellular carcinoma
por: Uranbileg, Baasanjav, et al.
Publicado: (2020)

Molecular mechanism of lysophosphatidic acid-induced hypertensive response
por: Kano, Kuniyuki, et al.
Publicado: (2019)

Increase in serum levels of phosphatidylserine-specific phospholipase A(1) in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2021)

The Lysophospholipase PNPLA7 Controls Hepatic Choline and Methionine Metabolism
por: Harada, Sayaka, et al.
Publicado: (2023)

Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids
por: Kurano, Makoto, et al.
Publicado: (2015)

Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain
por: Ma, Lin, et al.
Publicado: (2009)

Decrease in serum levels of autotaxin in COVID-19 patients
por: Shimura, Takuya, et al.
Publicado: (2022)

Gamma‐aminobutyric acid transaminase genetic polymorphism is a candidate locus for responsiveness to opioid analgesics in patients with cancer pain: An exploratory study
por: Yokoshima, Yaeko, et al.
Publicado: (2018)

Sphingosine kinase-2 prevents macrophage cholesterol accumulation and atherosclerosis by stimulating autophagic lipid degradation
por: Ishimaru, Kazuhiro, et al.
Publicado: (2019)

The Role of Lysophosphatidic Acid on Airway Epithelial Cell Denudation in a Murine Heterotopic Tracheal Transplant Model
por: Tando, Yukiko, et al.
Publicado: (2015)

Serum levels of apolipoprotein A-I and E are associated with postoperative delirium: A post hoc analysis
por: Mietani, Kazuhito, et al.
Publicado: (2022)

Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
por: Inoue, Makoto, et al.
Publicado: (2008)

Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2021)

Higher LPA2 and LPA6 mRNA Levels in Hepatocellular Carcinoma Are Associated with Poorer Differentiation, Microvascular Invasion and Earlier Recurrence with Higher Serum Autotaxin Levels
por: Enooku, Kenichiro, et al.
Publicado: (2016)

Serum GM3(d18:1-16:0) and GM3(d18:1-24:1) levels may be associated with lymphoma: An exploratory study with haematological diseases
por: Nishikawa, Masako, et al.
Publicado: (2019)

Dynamic modulations of sphingolipids and glycerophospholipids in COVID‐19
por: Kurano, Makoto, et al.
Publicado: (2022)

GPR34 in spinal microglia exacerbates neuropathic pain in mice
por: Sayo, Akira, et al.
Publicado: (2019)

Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin E metabolite as a novel biomarker of diabetic nephropathy
por: Morita, Yoshifumi, et al.
Publicado: (2021)

Characteristics of Locomotive Syndrome in Japanese Patients with Chronic Pain and Results of a Path Analysis Confirming the Relevance of a Vicious Cycle Involving Locomotive Syndrome, Musculoskeletal Pain, and Its Psychological Factors
por: Ushio, Michiko, et al.
Publicado: (2019)

Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries
por: Kurano, Makoto, et al.
Publicado: (2022)

Involvement of Band3 in the efflux of sphingosine 1-phosphate from erythrocytes
por: Kurano, Makoto, et al.
Publicado: (2017)

Identification of novel biomarkers of hepatocellular carcinoma by high‐definition mass spectrometry: Ultrahigh‐performance liquid chromatography quadrupole time‐of‐flight mass spectrometry and desorption electrospray ionization mass spectrometry imaging
por: Nagai, Koshi, et al.
Publicado: (2019)

Current Knowledge on the Biology of Lysophosphatidylserine as an Emerging Bioactive Lipid
por: Omi, Jumpei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_q7su00galk4t30e5gg1reqe8mr